ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,333, issued on Dec. 2, was assigned to EMSTOPA Ltd. (Sandwich, Great Britain).

"Tissue plasminogen activator antibodies and method of use thereof" was invented by James Carl Keith Jr. (Andover, Mass.), Alexander Noel Fraser Brown (Stevenage, Great Britain) and Preeti Bakrania (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides tissue plasminogen activator antibody molecules and their uses. More particularly, the presently-disclosed invention provides humanised antibody molecules which specifically bind tissue plasminogen activator (TPA) and their use in treating TPA induced haemorrhage, in particula...